WIPO

Data

Cmpds

HGNC*

WIPO Title

Organization

Deposition

Downloads

10

INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

MINDSET PHARMA INC.

03/05/23

2D 3D TSV

22

MAP4K1 INHIBITORS

BLUEPRINT MEDICINES CORPORATION

03/05/23

2D 3D TSV

42

HGNC:5294 5182

SEROTONIN 5-HT2A, 5-HT2B, AND 5-HT2C RECEPTOR INVERSE AGONISTS

NORTHEASTERN UNIVERSITY

03/05/23

2D 3D TSV

25

CDK7 SELECTIVE INHIBITORS AS ANTICANCER AGENTS

JINGRUI BIOPHARMA CO., LTD.

02/02/23

2D 3D TSV

13

M6PR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES

LYCIA THERAPEUTICS, INC.

02/02/23

2D 3D TSV

2

HGNC:2358 2357

NOVEL FATTY ACID MODIFIED UROCORTIN 2 DERIVATIVES AND THE USES THEREOF

NOVO NORDISK A/S

02/02/23

2D 3D TSV

25

TRICYCLIC COMPOUNDS

RECURIUM IP HOLDINGS, LLC

02/02/23

2D 3D TSV

22

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED DISEASES

NOVARTIS AG

01/31/23

2D 3D TSV

10

CORONAVIRUS MAIN PROTEASE INHIBITORS AND METHODS USING SAME

BAYLOR COLLEGE OF MEDICINE

01/31/23

2D 3D TSV

25

ETHER-LINKED ANTIVIRAL COMPOUNDS

PFIZER INC.

01/31/23

2D 3D TSV

30

INHIBITORS TARGETING UBIQUITIN SPECIFIC PROTEASE 7 (USP7)

DANA-FARBER CANCER INSTITUTE, INC.

01/31/23

2D 3D TSV

46

SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

SANOFI

12/30/22

2D 3D TSV

19

(AZA)BENZOTHIAZOLYL SUBSTITUTED PYRAZOLE COMPOUNDS

PFIZER INC.

12/14/22

2D 3D TSV

14

AMIDE DERIVATIVE HAVING ANTIVIRAL ACTIVITY

SHIONOGI & CO., LTD.

12/14/22

2D 3D TSV

25

AROMATIC BRIDGED RING AMIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

F. HOFFMANN-LA ROCHE AG

12/14/22

2D 3D TSV

26

AROMATIC SPIRO RING AMIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

F. HOFFMANN-LA ROCHE AG

12/14/22

2D 3D TSV

24

ARYLOXAZOLO SPIRAL RING DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

F. HOFFMANN-LA ROCHE AG

12/14/22

2D 3D TSV

21

INHIBITION OF TYK2 DEPENDENT SIGNALING PATHWAYS

JANSSEN PHARMACEUTICA NV

12/14/22

2D 3D TSV

24

ISOINDOLINONE COMPOUNDS

MONTE ROSA THERAPEUTICS AG

12/14/22

2D 3D TSV

22

MACROCYCLES CONTAINING A 1,3,4-OXADIAZOLE RING FOR USE AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

VERTEX PHARMACEUTICALS INCORPORATED

12/14/22

2D 3D TSV

26

MACROCYCLIC UREA OREXIN RECEPTOR AGONISTS

MERCK SHARP & DOHME LLC

12/14/22

2D 3D TSV

25

MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

MERCK SHARP & DOHME LLC

12/14/22

2D 3D TSV

33

N-SUBSTITUTED 4-(5-PHENYL-1,3,4-OXADIAZOL-2-YL)ANILINE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

F. HOFFMANN-LA ROCHE AG

12/14/22

2D 3D TSV

24

SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

F. HOFFMANN-LA ROCHE AG

12/14/22

2D 3D TSV

25

TETRAHYDROISOQUINOLINE DERIVATIVES FOR THE TREATMENT OF RED BLOOD DISORDERS AND INFLAMMATORY DISEASES

SANOFI

12/14/22

2D 3D TSV

110

3-AMINO PYRROLIDINE AND PIPERIDINE MACROCYCLIC OREXIN RECEPTOR AGONISTS

MERCK SHARP & DOHME LLC

10/05/22

2D 3D TSV

32

POLYHETEROCYCLIC GLP-1 R MODULATING COMPOUNDS

GILEAD SCIENCES, INC.

10/05/22

2D 3D TSV

31

SARS-COV-2 MPRO INHIBITOR COMPOUNDS

HEPTARES THERAPEUTICS LIMITED

10/05/22

2D 3D TSV

49

1-(2-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YL)ACETYL)-4-HYDROXY-N-(BENZYL)PYRROLIDIN E-2-CARBOXAMIDE DERIVATIVES AS VHL INHIBITORS FOR THE TREATMENT OF ANEMIA AND CANCER

GENENTECH, INC.

08/07/22

2D 3D TSV

42

1-(2-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YL)ACETYL)-4-HYDROXYPYRROLIDINE-2-CARBOXA|MIDE DERIVATIVES AS VHL INHIBITORS FOR THE TREATMENT OF ANEMIA

GENENTECH, INC.

08/07/22

2D 3D TSV

56

7-AZOLE SUBSTITUTED 2-AMINOQUINAZOLINE INHIBITORS OF HPK1

MERCK SHARP & DOHME LLC

08/07/22

2D 3D TSV

80

CYCLOPENTATHIOPHENE CARBOXAMIDE DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

08/07/22

2D 3D TSV

47

DIAMINOPYRIMIDINE CARBOXAMIDE INHIBITORS OF HPK1

MERCK SHARP & DOHME LLC

08/07/22

2D 3D TSV

14

N-[2-({4-[3-(ANILINO)-4-OXO-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-2-YL]PYRIDIN-3-YL)OXY)ETHYL]PROP-2-ENAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER

BAYER AKTIENGESELLSCHAFT

08/07/22

2D 3D TSV

34

PYRAZOLE DERIVATIVES ASR ET KINASE INHIBITORS

ELI LILLY AND COMPANY

08/07/22

2D 3D TSV

125

SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE

JANSSEN PHARMACEUTICA NV

08/07/22

2D 3D TSV

384

7-PHENYL SUBSTITUTED 2-AMINOQUINAZOLINE INHIBITORS OF HPK1

MERCK SHARP & DOHME LLC

07/22/22

2D 3D TSV

61

HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE

AMGEN INC.

07/21/22

2D 3D TSV

226

INTERLEUKIN-17 INHIBITORS

NOVARTIS AG

07/21/22

2D 3D TSV

236

N-LINKED ISOQUINOLINE AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

MERCK SHARP & DOHME LLC

07/21/22

2D 3D TSV

219

SUBSTITUTED 1H-PYRAZOLO[4,3-C]PYRIDINES AND DERIVATIVES AS EGFR INHIBITORS

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

07/21/22

2D 3D TSV

68

SUBSTITUTED MORPHOLINE COMPOUNDS

GENENTECH, INC.

07/21/22

2D 3D TSV

19

ANTIVIRAL HETEROARYL KETONE DERIVATIVES

PFIZER INC.

06/09/22

2D 3D TSV

80

NOVEL CORONAVIRUS MAIN PROTEASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF

SICHUAN UNIVERSITY

06/09/22

2D 3D TSV

29

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CRYPTOSPORIDIOSIS

NOVARTIS AG

05/24/22

2D 3D TSV

71

PHOSPHOLIPID COMPOUNDS AND USES THEREOF

GILEAD SCIENCES, INC.

05/24/22

2D 3D TSV

229

SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER

THE BROAD INSTITUTE, INC.

05/24/22

2D 3D TSV

68

SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER

THE BROAD INSTITUTE, INC.

05/24/22

2D 3D TSV

294

TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS

BRISTOL-MYERS SQUIBB COMPANY

05/24/22

2D 3D TSV

83

HGNC:3827 3826

AMINOIMIDAZOLE FPR2 AGONISTS

BRISTOL-MYERS SQUIBB COMPANY

05/02/22

2D 3D TSV

172

CYCLIN-DEPENDENT KINASE 7 (CDK7) NON-COVALENT INHIBITORS

JANSSEN PHARMACEUTICA NV

05/02/22

2D 3D TSV

25

DIHYDROOROTATE DEHYDROGENASE INHIBITORS

JANSSEN BIOTECH, INC.

05/02/22

2D 3D TSV

6

DIHYDROOROTATE DEHYDROGENASE INHIBITORS

JANSSEN BIOTECH, INC.

05/02/22

2D 3D TSV

8

DIHYDROOROTATE DEHYDROGENASE INHIBITORS

JANSSEN BIOTECH, INC.

05/02/22

2D 3D TSV

141

PREPARATION OF BENZIMIDAZOLONE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS

MERCK SHARP & DOHME CORP.

05/02/22

2D 3D TSV

168

PREPARATION OF OXINDOLE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS

MERCK SHARP & DOHME CORP.

05/02/22

2D 3D TSV

100

Aminocarbamoyl compounds for the treatment of viral infections

F. Hoffmann-La Roche Ag

03/30/22

2D 3D TSV

178

Sars-cov-2 inhibitors having covalent modifications for treating coronavirus infections

Insilico Medicine Ip Limited

01/27/22

2D 3D TSV

44

Compounds and method of treating covid-19

Pfizer Inc.

01/13/22

2D 3D TSV

3

Compounds and methods for the treatment of covid-19

Pfizer Inc.

01/13/22

2D 3D TSV

94

Nitrile-containing antiviral compounds

Pfizer Inc.

01/13/22

2D 3D TSV

12

Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis

Pfizer Inc.

01/31/21

2D 3D TSV

61

Anticoronviral compounds and compositions, their pharmaceutical uses and materials for their synthesis

Pfizer Inc.

10/17/20

2D 3D TSV